Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


N.Z. Delays H1N1 Vaccine Order Despite Pandemic Status

This article was originally published in PharmAsia News

Executive Summary

New Zealand's health authorities are holding off responding to the World Health Organization's declaration of the H1N1 influenza virus as a "pandemic." CSL of Australia is gearing up to produce a vaccine based on a WHO-distributed strain, but New Zealand authorities say they have not decided whether or when to place a planned order for as many as 8 million doses with the company. The Health Ministry is undecided because it fears there may still be a need to purchase antivirals against seasonal flu and because the mild nature of the H1N1 cases found in New Zealand suggest the vaccines may not be necessary. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts